Persistent Negative Symptoms in Schizophrenia: An Overview

Por Buchanan, Robert W.
Publicado em 2007

William T. Carpenter Jr: 35 Years of Clinical Trials

Por Buchanan, Robert W.
Publicado em 2014

Fast facts : esquizofrenia /

Por Lewis, Shôn., Buchanan, Robert W.
Publicado em 2012

Early Intervention: How Early and With What?

Por Carpenter, William T., Buchanan, Robert W.
Publicado no Schizophr Bull (2015)

A Case of Complete Omphalocele

Por Buchanan, Robert W., Cain, Waldo L.
Publicado em 1956

Celebrating the Work of William T. Carpenter Jr

Por Lehman, Anthony F., Buchanan, Robert W.
Publicado em 2014

Review of Clinical Correlates of P50 Sensory Gating Abnormalities in Patients with Schizophrenia

Por Potter, David, Summerfelt, Ann, Gold, James, Buchanan, Robert W.
Publicado em 2006

The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials

Por Prentice, Kristen J., Gold, James M., Buchanan, Robert W.
Publicado em 2007

The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009

Por Kreyenbuhl, Julie, Buchanan, Robert W., Dickerson, Faith B., Dixon, Lisa B.
Publicado em 2010

Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models

Por Ahmed, Anthony O., Strauss, Gregory P., Buchanan, Robert W., Kirkpatrick, Brian, Carpenter, William T.
Publicado no Schizophr Bull (2015)

Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia

Por Buchanan, Robert W., Freedman, Robert, Javitt, Daniel C., Abi-Dargham, Anissa, Lieberman, Jeffrey A.
Publicado em 2007

Neuropsychology of the Deficit Syndrome: New Data and Meta-analysis of Findings To Date

Por Cohen, Alex S., Saperstein, Alice M., Gold, James M., Kirkpatrick, Brian, Carpenter, William T., Buchanan, Robert W.
Publicado em 2007

DIFFERENTIAL PATTERNS OF PREMORBID SOCIAL AND ACADEMIC DETERIORATION IN DEFICIT AND NONDEFICIT SCHIZOPHRENIA

Por Strauss, Gregory P., Allen, Daniel N., Miski, Pinar, Buchanan, Robert W., Kirkpatrick, Brian, Carpenter, William T.
Publicado em 2011

The Practice Research Network: A Collaboration Between the University of Maryland and the Public Mental Health System

Por Sundeen, Sandra J., Goldman, Howard H., Nieberding, Daniel J., Piez, Deborah A., Buchanan, Robert W.
Publicado em 2013

White Matter Alterations in Deficit Schizophrenia

Por Rowland, Laura M., Spieker, Elena A., Francis, Alan, Barker, Peter B., Carpenter, William T., Buchanan, Robert W.
Publicado em 2008

The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?

Por Buchanan, Robert W., Keefe, Richard S. E., Umbricht, Daniel, Green, Michael F., Laughren, Thomas, Marder, Stephen R.
Publicado em 2011

Changes in Academic and Social Premorbid Adjustment across Sex and Developmental Period in Individuals with Schizophrenia

Por Allen, Daniel N., Strauss, Gregory P., Barchard, Kimberly A., Vertinski, Mary, Carpenter, William T., Buchanan, Robert W.
Publicado em 2013

Community Adherence to Schizophrenia Treatment and Safety Monitoring Guidelines

Por Keller, William R., Fischer, Bernard A., McMahon, Robert, Meyer, Walter, Blake, Melissa, Buchanan, Robert W.
Publicado no J Nerv Ment Dis (2014)

Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?

Por Keefe, Richard S. E., Buchanan, Robert W., Marder, Stephen R., Schooler, Nina R., Dugar, Ashish, Zivkov, Milana, Stewart, Michelle
Publicado em 2013

A REVIEW OF ANTI-INFLAMMATORY AGENTS FOR SYMPTOMS OF SCHIZOPHRENIA

Por Keller, William R., Kum, Lionel M., Wehring, Heidi J., Koola, Maju Mathew, Buchanan, Robert W., Kelly, Deanna L.
Publicado em 2012